CD8A and neoplasm: To investigate further a role for CD8+ and CD4+ T cells in mediating anti-tumor responses in WT mice, we treated EMT6 and EMT6siCD200 tumor bearing animals with either an anti-CD8 or anti-CD4 depleting antibody beginning at day 6 post tumor cell injection (x3 injections).